Sylvester Comprehensive Cancer Center

News

J. William Harbour, M.D.

Sylvester Associate Director Receives $2.5 Million Grant for Predictive Testing of Ocular Melanoma

05.23.2017

J. William Harbour, M.D., associate director for basic research at Sylvester, and the Mark J. Daily Chair and vice chairman for translational research at the Bascom Palmer Eye Institute, has been awarded a $2.5 million grant from the National Cancer Institute, a division of the National Institutes of Health (NIH), to study predictive testing of ocular (or uveal) melanoma, one of the deadliest types of cancer.

From left, medical student Owen Tan with Nagi G. Ayad, Ph.D.

Student Researcher Owen Tan Named 2017 St. Baldrick’s Summer Fellow

05.11.2017

To support his research at Sylvester Comprehensive Cancer Center, Owen Tan, a student at the University of Miami Miller School of Medicine, has been awarded a $5,000 summer fellowship grant from the St. Baldrick’s Foundation. The Miller School is one of only 21 institutions in the U.S. — and the only one in Florida — to receive a grant. Tan plans to use his to support his research into pediatric brain tumors.

Fluorescence microscopy of islets in the omentum transplanted within the biologic scaffold. Shown in red (insulin staining) and blue (DAPI nuclear staining).

Research Findings Show Tissue-Engineered Islet Transplant Achieves Insulin Independence

05.10.2017

Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have produced the first clinical results demonstrating that pancreatic islet cells transplanted within a tissue-engineered platform can successfully engraft and achieve insulin independence in type 1 diabetes. The findings were published in the May 11 issue of the New England Journal of Medicine.

Tumor-cell infiltration into the liver of a TET2-ko mouse.

Studying a Catalyst for Blood Cancers

04.25.2017

Mingjiang Xu, M.D., Ph.D., cancer researcher at Sylvester Comprehensive Cancer Center, and colleagues have been studying the protein TET2, a tumor suppressor, for several years. They recently published a paper in the prestigious journal Nature Communications, which describes how TET2 loss can open the door for mutations that drive myeloid, lymphoid, and other cancers.

AML cells under the microscope. Source: The website of the National Cancer Institute (https://www.cancer.gov).

Researchers show p300 protein may suppress leukemia in MDS patients

03.27.2017

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may stop myelodysplastic syndrome (MDS) from developing into acute myeloid leukemia (AML). The study was published in the journal Leukemia.

Thinh Tran, M.D., MBA., chief clinical officer and chief operating officer, joins the hand sanitizer mascot at Bascom Palmer Eye Institute.

Successful Patient Safety Week Concludes

03.17.2017

Friday was the fifth and final day of Patient Safety Week activities. With the theme of the day being preventing infection, hands across campus were washed and sanitized in record numbers. Hand sanitizer bottles were given away throughout UHealth locations, and the Hand Sanitizer Mascot made surprise inspirational appearances.

From left, student pharmacist Bibi Barrios with UMH Pharmacy Clinical Manager Marlene Delavalle, Pharm.D.

Patient Safety Week Activities Continue on Thursday

03.14.2017

Wednesday, the third day of Patient Safety Week, focused on the safe use of medications. It was a day of important educational outreach, an amusing but informative takeoff on the TV game show “Jeopardy” and an opportunity for UHealth’s pharmacy experts to enjoy some time in the spotlight. Thursday’s activities will focus on the safe use of alarms.

Joining David J. Birnbach, M.D., M.P.H., senior associate dean for quality, safety and risk prevention, are, from left, Myka Whitman, B.S.N., RN, interim UHealth chief risk officer, Kathy Zanelli, B.S.N., RN, executive director of nursing, Gissette Onorato, executive director of human experience, Maureen Fitzpatrick, M.S.N., ARNP-BC, of the Center for Patient Safety, and Roxanna Araya of the Center for Patient Safety.

Patient Safety Week Activities Continue on Friday

03.14.2017

Thursday, the fourth day of Patient Safety Week, focused on the safe use of clinical alarms. UHealth staff learned about finding the proper balance between alarms that go off too regularly — and therefore get ignored, and those that don’t go off often enough, and potentially endanger patients in need of assistance.